National Meeting of Policymakers on Public Health and Intellectual Property, 17 June, 2019.
Event details
The South Centre and the Egyptian Intellectual Property Office (EGPO) are organizing a national seminar on sharing and exchanging experiences among different policymakers on policy options pursued at the global, regional and national level to make full use of the TRIPS flexibilities to support access to medicines. The seminar will be held at the Pyramisa Suites Hotel in Cairo, Egypt, on 17 June 2019. This seminar will share the experience of negotiations related to IP and access to medicines in the World Intellectual Property Organization, the World Health Organization and the World Trade Organization, as well as debates in several other international forums. It will also address key themes for the contemporary intellectual property and public health agenda in Egypt and around the world, including interpretations of TRIPS relating to patents of second use, polymorphs, Markush formulas, etc.
Training and other supporting material
- Seminar Agenda
- List of Speakers
- Relationship between Patents and Public Health_PasswordRequired
- Salient Features of the Patent Law of Egypt in the Context of Public Health_PasswordRequired
- TRIPS Plus provisions in FTAs_PasswordRequired
- Use of TRIPS flexibilities to scale-up HCV treatments_PasswordRequired
- Patent & Public Health in Egypt IP Law - 2019_PasswordRequired
- The Egyptian Experience in Examination of Pharmaceutical Patents The Law and Practice_PasswordRequired
- Patents and Public Health Policy in Egypt_PasswordRequired
- Patent Examination and Legal Fictions: How Rights are Created on Feet of Clay
- Guidelines on Patentability and Access to Medicines
- Implementing Pro-Competitive Criteria for the Examination of Pharmaceutical Patents
- Tackling the Proliferation of Patents: How to Avoid Undue Limitations to Competition and the Public Domain
- Intellectual Property in the Trans-Pacific Partnership: Increasing the Barriers for the Access to Affordable Medicines
- Access to Medicines: Experiences with Compulsory Licenses and Government Use – The Case of Hepatitis C
- Public health related TRIPS-plus provisions in bilateral trade agreements